Dukoral

Țară: Uniunea Europeană

Limbă: engleză

Sursă: EMA (European Medicines Agency)

Cumpara asta acum

Prospect Prospect (PIL)
06-04-2022

Ingredient activ:

recombinant cholera toxin B subunit, vibrio cholerae 01

Disponibil de la:

Valneva Sweden AB

Codul ATC:

J07AE01

INN (nume internaţional):

cholera vaccine (inactivated, oral)

Grupul Terapeutică:

Vaccines

Zonă Terapeutică:

Cholera; Immunization

Indicații terapeutice:

Dukoral is indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children from 2 years of age who will be visiting endemic/epidemic areas.The use of Dukoral should be determined on the basis of official recommendations taking into consideration the variability of epidemiology and the risk of contracting disease in different geographical areas and travelling conditions.Dukoral should not replace standard protective measures. In the event of diarrhoea measures of rehydration should be instituted.

Rezumat produs:

Revision: 14

Statutul autorizaţiei:

Authorised

Data de autorizare:

2004-04-28

Prospect

                                22
B. PACKAGE LEAFLET
23
PACKAGE LEAFLET: INFORMATION FOR THE USER
DUKORAL SUSPENSION AND EFFERVESCENT POWDER FOR ORAL SUSPENSION
Cholera vaccine (inactivated, oral)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS VACCINE
BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor, nurse or
pharmacist.
-
This vaccine has been prescribed for you only. Do not pass it on to
others.
-
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See Section 4.
-
Make sure to mix the vaccine with buffer solution as described in this
leaflet. See Section 3.
WHAT IS IN THIS LEAFLET
:
1.
What Dukoral is and what it is used for
2.
What you need to know before you use Dukoral
3.
How to use Dukoral
4.
Possible side effects
5
How to store Dukoral
6.
Contents of the pack and other information
1.
WHAT DUKORAL IS AND WHAT IT IS USED FOR
Dukoral is an oral vaccine against cholera that stimulates the
immunological defence in the gut. The
vaccine protects adults and children from 2 years of age against
cholera.
Dukoral causes your body to produce its own protection against
cholera. After getting the vaccine,
your body will make substances called antibodies, which fight the
cholera bacteria and toxin that
cause diarrhoea.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE DUKORAL
DO NOT USE DUKORAL
•
if you are allergic to any ingredient of the vaccine or to
formaldehyde.
•
if you have an acute stomach disorder or infection with fever
(vaccination should be delayed).
WARNINGS AND PRECAUTIONS
Talk to your doctor before taking Dukoral
•
if you take a medical treatment that affects the immune system
•
if you have a disease of the immune system (including HIV infection).
The vaccine may provide you with a lower level of protection than it
does for people with healthy
immune systems.
The vaccine does not provide complete protection and it is important
to 
                                
                                Citiți documentul complet
                                
                            

Caracteristicilor produsului

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
_ _
Dukoral suspension and effervescent powder for oral suspension
Cholera vaccine (inactivated, oral)
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each dose of vaccine suspension (3 ml) contains:
−
A total of 1.25x10
11
bacteria of the following strains:
_Vibrio cholerae_
O1 Inaba, classical biotype
_ _
(heat inactivated)
31.25x10
9
bacteria*
_Vibrio cholerae_
O1 Inaba, El Tor biotype (formalin inactivated)
31.25x10
9
bacteria*
_Vibrio cholerae_
O1 Ogawa, classical biotype (heat inactivated)
31.25x10
9
bacteria*
_Vibrio cholerae_
O1 Ogawa, classical biotype (formalin inactivated)
31.25x10
9
bacteria*
−
Recombinant cholera toxin B subunit (rCTB)
1 mg
(produced in
_V. cholerae_
O1 Inaba, classical biotype strain 213.)
* Bacterial count before inactivation.
Excipients:
Sodium dihydrogen phosphate dihydrate 2.0 mg, disodium hydrogen
phosphate dihydrate 9.4 mg,
sodium chloride 26 mg, sodium hydrogen carbonate 3600 mg, sodium
carbonate anhydrous 400 mg,
saccharin sodium 30 mg, sodium citrate 6 mg.
One dose contains approximately 1.1 g sodium.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension and effervescent powder for oral suspension:
-
Suspension for oral suspension
-
Powder for oral suspension in a sachet.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Dukoral is indicated for active immunisation against disease caused by
_Vibrio cholerae_
serogroup O1
in adults and children from 2 years of age who will be visiting
endemic/epidemic areas.
The use of Dukoral should be determined on the basis of official
recommendations taking into
consideration the variability of epidemiology and the risk of
contracting disease in different
geographical areas and travelling conditions.
Dukoral should not replace standard protective measures. In the event
of diarrhoea measures of
rehydration should be instituted.
3
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Primary vaccination schedule _
The standard primar
                                
                                Citiți documentul complet
                                
                            

Documente în alte limbi

Prospect Prospect bulgară 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului bulgară 06-04-2022
Raport public de evaluare Raport public de evaluare bulgară 06-04-2022
Prospect Prospect spaniolă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului spaniolă 06-04-2022
Raport public de evaluare Raport public de evaluare spaniolă 06-04-2022
Prospect Prospect cehă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului cehă 06-04-2022
Raport public de evaluare Raport public de evaluare cehă 06-04-2022
Prospect Prospect daneză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului daneză 06-04-2022
Raport public de evaluare Raport public de evaluare daneză 06-04-2022
Prospect Prospect germană 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului germană 06-04-2022
Raport public de evaluare Raport public de evaluare germană 06-04-2022
Prospect Prospect estoniană 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului estoniană 06-04-2022
Raport public de evaluare Raport public de evaluare estoniană 06-04-2022
Prospect Prospect greacă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului greacă 06-04-2022
Raport public de evaluare Raport public de evaluare greacă 06-04-2022
Prospect Prospect franceză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului franceză 06-04-2022
Raport public de evaluare Raport public de evaluare franceză 06-04-2022
Prospect Prospect italiană 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului italiană 06-04-2022
Raport public de evaluare Raport public de evaluare italiană 06-04-2022
Prospect Prospect letonă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului letonă 06-04-2022
Raport public de evaluare Raport public de evaluare letonă 06-04-2022
Prospect Prospect lituaniană 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului lituaniană 06-04-2022
Raport public de evaluare Raport public de evaluare lituaniană 06-04-2022
Prospect Prospect maghiară 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului maghiară 06-04-2022
Raport public de evaluare Raport public de evaluare maghiară 06-04-2022
Prospect Prospect malteză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului malteză 06-04-2022
Raport public de evaluare Raport public de evaluare malteză 06-04-2022
Prospect Prospect olandeză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului olandeză 06-04-2022
Raport public de evaluare Raport public de evaluare olandeză 06-04-2022
Prospect Prospect poloneză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului poloneză 06-04-2022
Raport public de evaluare Raport public de evaluare poloneză 06-04-2022
Prospect Prospect portugheză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului portugheză 06-04-2022
Raport public de evaluare Raport public de evaluare portugheză 06-04-2022
Prospect Prospect română 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului română 06-04-2022
Raport public de evaluare Raport public de evaluare română 06-04-2022
Prospect Prospect slovacă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului slovacă 06-04-2022
Raport public de evaluare Raport public de evaluare slovacă 06-04-2022
Prospect Prospect slovenă 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului slovenă 06-04-2022
Raport public de evaluare Raport public de evaluare slovenă 06-04-2022
Prospect Prospect finlandeză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului finlandeză 06-04-2022
Raport public de evaluare Raport public de evaluare finlandeză 06-04-2022
Prospect Prospect suedeză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului suedeză 06-04-2022
Raport public de evaluare Raport public de evaluare suedeză 06-04-2022
Prospect Prospect norvegiană 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului norvegiană 06-04-2022
Prospect Prospect islandeză 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului islandeză 06-04-2022
Prospect Prospect croată 06-04-2022
Caracteristicilor produsului Caracteristicilor produsului croată 06-04-2022
Raport public de evaluare Raport public de evaluare croată 06-04-2022

Căutați alerte legate de acest produs

Vizualizați istoricul documentelor